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 29 
ABSTRACT: 30 
The electrostatic potential plays a key role in many biological processes like determining the affinity of a 31 
ligand to a given protein target, and they are responsible for the catalytic activity of many enzymes. 32 
Understanding the effect that amino acid mutations will have on the electrostatic potential of a protein, will 33 
allow a thorough understanding of which residues are the most important in a protein. MutantElec, is a 34 
friendly web application for in silico generation of site-directed mutagenesis of proteins and the comparison 35 
of electrostatic potential between the wild type protein and the mutant(s), based on the three-dimensional 36 
structure of the protein.  The effect of the mutation is evaluate using different approach to the traditional 37 
surface map. MutantElec provides a graphical display of the results that allows the visualization of changes 38 
occurring at close distance from the mutation and thus uncovers the local and global impact of a specific 39 
change. 40 
 41 
Availability: http://structuralbio.utalca.cl/mutantelec/ 42 
 43 
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 57 
INTRODUCTION 58 
 59 
The electrostatic potential at the surface of biological macromolecules such as proteins and nucleic acids 60 
plays a key role in many biological processes. Electrostatic interactions (EIs) and hydrophobic interfaces 61 
guide substrates and ligands to their designated location, and govern all protein interactions with other 62 
macromolecules, [1], [2]. EIs  play a key role in determining the affinity of a ligand to a given protein target, 63 
and they are responsible for the catalytic activity of many enzymes. One well-studied example is the 64 
Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase (PEPCK) where the binding of the Mn+2 65 
required for catalysis, is due to the EIs to the side chains of  a Lys213 [3], [4]. The reversible interaction 66 
between protein and membrane is critical to many biological processes [5] and these associations have been 67 
shown to be partly mediated by electrostatic interactions [6], [7]. Also, electrostatic charge distribution of 68 
interacting protein surfaces determines the formation or stabilization of many protein complexes. Thereafter, 69 
the mutation of a few or even a single residue can induce the destabilization of the interface [8]. This is the 70 
case of the yeast mitochondrial malate dehydrogenase where mutation of His46, located in the α-C helix of 71 
the binding interface between monomers, results in the loss of polar interactions at the subunit interface and 72 
ultimately the dissociation of the dimer [9]. Substantial evidence of the effect of charge distributions on the 73 
functional characteristics of proteins can also be found in the literature. For example, the ability of the 74 
transcriptional regulators of the Ferric Uptake Regulator (Fur) family to bind and recognize specific DNA 75 
sequences at the promoter regions of their target genes is directly correlated with the electric charge 76 
distribution of the DNA binding site of these protein [10–12].  77 
 78 
The electrostatic potential (EPs) of biological macromolecules can be estimated using Poisson-Boltzmann 79 
(PB) equations, and several software packages, such as APBS [13] and Delphi [14], have been developed to 80 
solve these equations. Many of these software take advantage of novel computational approaches, such as 81 
Grid computing for distributed calculations [15], and the use of graphic processor units (GPU) for 82 
electrostatic potential calculations [16], which enable calculations to be done in a matter of minutes. EPs are 83 
most conveniently displayed as color-coded surface representations using modern graphical programs such as 84 
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JSmol (http://www.jmol.org/), Pymol (http://www.pymol.org/), and VMD [17]. However, none of these tools 85 
reveals the net effect on the EP of the target proteins, nor on the global charge distribution of in silico mutant 86 
variants of the protein of interest. 87 
 88 
Site-directed mutagenesis is a standard experimental technique used to generate site-specific mutations in 89 
known protein-coding genes. By deleting or substituting particular residues, the role of individual amino acids 90 
in the reaction mechanisms of enzymes or in the structural configuration of proteins can be studied [18–22]. 91 
However, this technique is very laborious and time consuming, and in silico tools to help direct the selection 92 
of candidate residues are scarce. 93 
 94 
In spite of tremendous advances in molecular modeling and bioinformatics software, the in-silico design of 95 
single-site mutant variants and their evaluation requires significant expertise in various sophisticated 96 
bioinformatics tools designed for protein modeling and ligand analyses [24]. Molecular modelling software 97 
packages (e.g. VMD [17], ICM [25], SwissPDB [26], VegaZZ [27]) can generate the in silico mutants by 98 
replacement of residues, one at a time, but they do not calculate the new electrostatic surface automatically, 99 
and do not provide an automated pipeline to generate a series of mutations. Only recently, programs such as 100 
SAAMBE [28] and SAAFEC [29] have been developed, that allow the prediction of the changes in the free 101 
energy of binding and protein folding respectively, caused by amino acids mutations  In addition, programs 102 
like BeAtMuSiC [30] and PoPMuSiC-2.0 [31] can predict the changes in protein–protein binding affinity and 103 
on protein stability as a consequence of in silico mutation. However, none of those programs allow the 104 
prediction of the changes that mutations will have in the EP of a protein. In turn, Delphi [14] performs 105 
versatile electrostatic potential calculations, but lacks the ability to generate in silico mutations. Importantly, 106 
most programs do not take into account non-natural amino acids, e.g., those are phosphorylated and 107 
dephosphorylated as part of the regulatory mechanism of the cell. Being such an important process in cellular 108 
regulatory networks [33,34], exclusion of phosphorylated residues is an important caveat that limits adequate 109 
study of the effect of mutations in EP calculations. 110 
 111 
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Despite the many virtues of the alluded software, most of them are not user friendly and require considerable 112 
expertise from the user. For example, some lack the option to input a PDB identifier to initiate the job. Others 113 
lack simplicity in their mutation interface: the users must specify manually the code, chain and number of the 114 
residue they wish to mutate, along with the new residue. In most applications this step is not automatically 115 
validated, and represents a source of errors to biologists with little or none computational knowledge.  116 
Furthermore, except for Delphi, none of the applications discussed has an online side-by-side comparison 117 
interface between the wild type and the mutant protein 118 
 119 
To tackle the impairments alluded to above, we designed MutantElec, a web-based application for the study 120 
of the effects that mutations have in the EP of a protein of interest. It simulates in silico site-directed 121 
mutations and analyzes their effect on the EP distribution of the mutated protein. MutantElec provides a 122 
graphical display that allows the visualization of changes occurring at any distance from the introduced point 123 
mutation and, thus, uncovers both the local and global effects of a site-specific change. This application is 124 
user friend and easy to use, and has thus the potential to control frequent errors associated to misusage. We 125 
are confident that MutantElec will prove particularly valuable in the analysis of mutations involving amino 126 
acids with similar physicochemical properties and those that are target of posttranslational modifications 127 
(such as phosphorylation), where currently available graphical representations of the whole protein surface 128 
obscure small changes of the electrostatic potential. 129 
 130 
METHODS 131 
 132 
The MutantElect web application is based on an intuitive graphical user interface with three main component 133 
layers: 1) an INPUT layer, through which a protein structure in PDB format is selected and uploaded into the 134 
system, 2) an ANALYSIS layer comprising several subroutines that simulate the mutation(s) chosen by the 135 
user and estimates the electrostatic potential configuration of the wild type and mutated variants of the target 136 
protein, and 3) an OUTPUT layer, involving a set of subroutines for the display of the results in a user-137 
friendly and intuitive graphical environment. 138 
 139 
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Multiple in-house scripts written in TCL and Perl programming languages were created to process and 140 
connect the input and output files of the various programs used along the pipeline, including the software used 141 
for mutation (Modeller, [32]),  for EP calculations (APBS, [13]), as well as for automating the process (Figure 142 
1).  143 
 144 
INPUT layer: Consulting web interface 145 
 146 
The first part of the system comprises the web interface that allows the user to choose the type of analysis and 147 
upload the target protein. The input data upload and consultation web interface was built using HTML, 148 
JavaScript and PHP languages, in a simple and intuitive web environment (Figure 2). The user can choose 149 
between two basic analyses: 1) site-specific mutagenesis and 2) mutagenesis of a specific region. The “site-150 
specific mutagenesis” option enables the user to select the residue that is to be mutated and to specify the 151 
desired amino-acid exchange. Furthermore, through this option, any residue can be substituted by all the other 152 
19 common amino acids using a scanning procedure (Figure 1S, Additional file 1), facilitating exploration of 153 
the most perturbing and least perturbing changes. In turn, the “mutagenesis of a specific region” option 154 
enables the user to mutate up to 10 amino acids in a row, in any selected region of the target protein (Figure 155 
2S, Additional file 1). Alternatively, the user can upload a native and a mutant protein obtained 156 
experimentally, to compare the EPs of both using the tool without simulating mutations in silico. 157 
 158 
After choosing the type of analysis, the UPLOAD query form can be accessed for the user to upload a PDB 159 
file containing the 3D coordinates of the protein of interest. The coordinate file can be obtained from the PDB 160 
database or from a model generated by the user through comparative modelling, following the instructions 161 
provided. The file can be then processed to check the amino acid composition. If a non-standard residue is 162 
found, a warning is displayed indicating this residue was deleted of the analysis.  The user must modify the 163 
PDB file by exchanging or removing the non-standard residues (eg: HETATM, ligand, etc) previously. This is 164 
important because the force field calculations do not generate appropriate parameters for non-standard 165 
residues. 166 
 167 
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Once the PDB file has been uploaded, the web interface displays all the amino acids in the target protein as a 168 
list, ordered numerically from the N- to the C-terminus. The user has then the option to select the residues to 169 
be mutated and the corresponding substitutions. Most commonly phosphorylated residues (phosphoserine, 170 
phosphothreonine, phosphotyrosine) available for the Force Field CHARMM [35] are also considered in the 171 
MutantElec pipeline. Additionally, the user can modify the parameters used to calculate the electrostatic 172 
potential through the APBS software (dielectric constant of the biomolecule, dielectric constant of the solvent, 173 
temperature). The default options used in the subsequent analyses are those of proteins under mesophilic 174 
conditions having water as solvent, i.e. temperature = 25°C and dielectric constant of water = 78.5. Once the 175 
job is submitted, calculations are sent to the job queue, where the request is processed. 176 
 177 
ANALYSIS layer: Mutation and electrostatic properties calculation  178 
 179 
Amino acid mutation in the 3D structure of the protein is performed by the Mutate module from the Modeller 180 
software [33]. The conformation of the mutant sidechain is optimized by energy minimization (conjugate 181 
gradient) and refined using a small number of steps of molecular dynamics as implemented in Modeller [34]. 182 
The generated 3D coordinates are then processed using the PDB2PQR software [35] to assign charge and 183 
radius parameters for each atom. This information is stored in the pqr file and used for further calculation of 184 
the electrostatic potential using  the Poisson-Boltzmann (PB) equations as implemented in the APBS software 185 
[13]. Then, the ANALYSIS subroutines estimate the electrostatic potential of each amino acid residue in the 186 
input protein and the mutant variant, based on the known structural conformation of the input protein. Next, 187 
the variation in the electrostatic potential distribution caused by the mutation introduced is calculated. These 188 
changes are not only related to the point mutation introduced in the target protein (i.e. change of electrostatic 189 
charge associated to a single residue), but also to conformational changes of the mutant variant. These 190 
changes need to be assessed before the EP distribution of the mutant protein is recalculated. For this purpose 191 
the system does a fast optimization using the Optimizers Module from Modeller [36] through the conjugate 192 
gradients method and molecular dynamics simulation. After the spatial conformation of the mutant variant is 193 
estimated, its EP distribution is calculated. A detailed report of the observed changes in the EP associated 194 
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with the point mutation is then provided to the user. Multiple single mutations can be queried simultaneously 195 
without limitation and results are conveniently delivered as independent reports for each request processed. 196 
 197 
OUTPUT layer: Information retrieval 198 
 199 
The results are processed to generate files containing the EP per residue per protein. This is done because the 200 
APBS results contain the EP per atom, and having the information in this format would make interpreting the 201 
results a difficult task. For this, an in-house script was written, that takes the output from APBS, and 202 
calculates the “per residue EP” by summing the individual contributions of each atom of every residue of a 203 
given protein. Results are presented as numerical and graphical outputs, displayed online as a set of charts 204 
which plot the per residue EP distribution of the input protein (Figure 3Sa, Additional file 1) and the mutant 205 
variant (Figure 3Sb, Additional file 1), individually or combined (Figure 3Sc, Additional file 1). The 206 
difference in EP between the input protein and the mutant variant generated by MutantElec are also displayed 207 
(Figure 3Sd, Additional file 1). A summative chart is plotted, which integrates all the above results in a single 208 
figure (Figure 3A) which is accompanied by a close-up representation of the mutation site and its neighboring 209 
residues within a sphere of selection of 15Å (a default value, that can be manipulated at will by the user) This 210 
is exemplified in Figure 3B, using the Ferric uptake regulator from P. aeruginosa FurPA (PDB_ID:1MZB) 211 
[12], and a simulated substitution of residue Glu100 for Ile. 212 
 213 
To evaluate the significance of the differences in the electrostatic potential uncovered between the input and 214 
the mutant protein, MutantElec performs the non-parametric Wilcoxon Signed-Rank Test, with a confidence 215 
level of 0.05 [37]. Additionally, the electrostatic potential maps of the surfaces are produced using JSmol 216 
(Figure 4S, Additional file 1). This facilitates the analysis of the results without the need to install and master 217 
additional programs, allowing the user to identify all potentially important changes in specific regions upon 218 
mutation, and to predict the impact of site directed mutations on protein structure and/or function. Finally, the 219 
application generates a compressed file (file *.tar.gz) with all the results, for the users to download and 220 
perform their own local analyses if deemed necessary. This file also contains the input and output files that 221 
were generated during the analysis run (Table 1). The user is notified via an email that includes links to 222 
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preview and download of the results. All results are also available in plain text format and can be exported 223 
into a spreadsheet for further analysis. 224 
 225 
Website 226 
 227 
MutantElec is freely available for non-commercial use at http://structuralbio.utalca.cl/mutantelec/. This server 228 
is supported by the Center of Bioinformatics at the University of Talca, and will be constantly updated and 229 
maintained to ensure reliable and continuous operation.  230 
 231 
EXAMPLE: p53 protein. 232 
 233 
The tumor suppressor protein p53 is a small transcription factor (393 amino acid) that binds to specific DNA 234 
sequences and regulates the expression of genes involved in DNA repair, cell cycle arrest, and apoptotic cell 235 
death [38]. This protein has been shown to play a key role in many human cancers and it is now estimated that 236 
approximately 50% of human tumors contain mutations in this gene [39]. It has several functional domains, 237 
including a transcriptional activation domain at its N-terminus, a sequence-specific DNA-binding domain 238 
(core domain), an oligomerization domain and a regulatory basic domain at the C-terminus. A wide range of 239 
structural and computational studies have contributed to unraveling the structural basis of activation and DNA 240 
binding [38,40,41].  241 
 242 
Alterations in the human p53 protein have been shown to result in a partial or total loss of its ability to bind 243 
DNA and correlated with increased probabilities of developing tumors [42]. This has triggered growing 244 
interests in characterizing the structural effects that point mutations have on p53 function and cancer 245 
development [38,43–46]. However, evaluation of these mutations require complex analyses in the areas of 246 
biochemistry, molecular biology and biophysics that are typically time-consuming and are only possible with 247 
significant resources [39]. The results of such studies show that certain mutations in p53 can affect its 248 
structure or modify its non-covalent interactions, causing conformational changes that lead to non-functional 249 
proteins. [39]. In turn, tools like CellDesigner, have been used successfully to aid in the selection and 250 
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evaluation of drug targets for p53 [47]. However, this approach does not address the effects of the point 251 
mutations introduced on the proteins EP distribution or its potential effects. 252 
 253 
As an example of the capabilities of MutantElec, the potential effect of mutating residue Arg249 in the DNA-254 
binding domain of p53 was evaluated. This residue has one of the highest mutation rates present in patients 255 
that have developed cancer [48]. In the IARC TP53 database [49] the following mutations of residue 249 have 256 
been described R249S/G/I/K/M/N/T/W. Interestingly, although residue R249 does not directly mediate p53 257 
binding to DNA [46], its mutation inactivates its function, suggesting that alterations of the neighboring 258 
regions caused by the point mutation. 259 
 260 
Using MutantElec and the PDB_ID 1TUP [28] containing the 3D structure of the human p53 core domain as 261 
input protein, all the above mentioned mutations were generated in silico. The Arg249 residue was replaced 262 
with all of the other 19 natural amino-acids, using the “scanning” option of the program (Figure 1S, 263 
Additional file 1) and the EPs and the difference in EP between the wild type and each mutant versions of p53 264 
were calculated and analyzed. The changes in the EP profiles for residues located less than 15Å apart from 265 
Arg249 are shown in Figure 4. The majority of mutations resulted in negative EP differences in the 266 
neighborhood of Arg249, with Glu249 and Asp249 being the two mutations that produced the most 267 
significant EP changes in the vicinity of the target residue. The profiles obtained indicate that these changes 268 
have an impact beyond the mutated residue, an effect that can also be observed in the electrostatic potential 269 
map (Figure 4S, Additional file 1). Further analyses on the effect of mutations of Arg249 with known 270 
inactivating effects on p53 (R249S/G/I/K/M/N/T/W) are displayed in Figure 5. The residues that produced 271 
major local changes in the EP were the negatively charged ones (Glu and Asp).  The Lys249 mutation, in 272 
turn, was the only one to produce a positive change in the local EP. 273 
 274 
The analysis with MutantElec also revealed which amino acids were most affected by the in silico mutation 275 
procedure. These residues were Tyr163, His168, Met246, Glu171, Ser166, Glu285 in decreasing order of 276 
magnitude, all of which have polar side chains with the exception of Met246 (Figure 6A). The spatial 277 
distribution of these residues (Figure 6B) reveals that they are less than 5Å away from the mutated Arg249 278 
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with the sole exception of residue Glu285 (<10Å). According to the IARC TP53 database, the most frequently 279 
encountered missense mutations that inactivate p53 are Met246, Glu171, His168 and Tyr163 (Table 2S, 280 
Supplementary material). These same four mutations, plus Val173 and Ser166, were uncovered by 281 
MutantElec as the ones with the most perturbing effects in the electrostatic potential of the DNA binding 282 
domain, and thus potentially affecting the capacity of p53 to bind its target DNA sequence. This provides an 283 
example of the value of MutantElec to predict and explain important biological changes due to single site 284 
variations or systematic scanning of perturbations in a protein sequence.  285 
 286 
CONCLUSIONS  287 
 288 
MutantElec is a rapid and simple bioinformatic tool that can be used to predict and evaluate changes in the 289 
charge distribution of a protein after mutating, in silico, one or several amino acids. This information can be 290 
extremely useful for understanding the contribution and importance of specific amino acids to protein 291 
function. In addition, MutantElec can aid the understanding of how mutations can cause malfunctions of 292 
enzymes and the resulting physiological changes that cause diseases. It is also a useful tool for the rational 293 
design of site-directed mutagenesis experiments. MutantElec is user friendly and can be used by scientists 294 
who do not have extensive training in bioinformatics and structural biology. It is expected that MutantElec 295 
will be a useful tool for teaching and training in protein science and medicine. 296 
 297 
 298 
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FIGURE 377 
Figure 1 workflow of the MutantElect web application. The three layers are color-coded and the components 378 
of each layer are represented accordingly. External software packages used in the pipeline are represented by 379 
the parallelogram while in-house developments (scripts and subroutines) are shown as rectangles. INPUT 380 
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layer (N° 1). Routine used to upload the input PDB file and to define the mutations to be performed. 381 
ANALYSIS layer (N° 2). Module employed in the generation of the in silico mutations and the calculation of 382 
the electrostatic potential. OUTPUT layer (N° 3). Subroutines in charge of performing the statistical analyses 383 
and comparisons and in generating the output. 384 
 385 
Figure 2: Consulting web interface of MutantElec. A: Analysis options, namely “site-specific” or “specific 386 
region” of the target protein and entry form for input data upload. B: Calculation parameters and default 387 
values (temperature = 298.15 K (mesophilic conditions); dielectric constant of the water = 78.54; distance 388 
cutoff (radio of selection for the analysis) from the residue mutated = 15Å. C: Site-directed mutations 389 
selection scroll-down menu. The option “All (Scanning)” allows the calculation to be repeated 19 times for 390 
every other of the 19 possible residues. 391 
Figure 3: MutantElec analyzes. A: Combinatorial chart displaying the electrostatic potential of the input and 392 
mutant proteins, and the difference in potential between both. B: Scheme of the environment surrounding the 393 
mutated residue (Glu100Ile) for the protein FurPA (PDB_ID:1MZB) [12]. In red are residues around the 394 
mutated residue (in blue) within the selected sphere of 15Å ratio used for the analysis. This distance can be 395 
modified by the user in the parameter setting web page with the option “Distance cutoff”. 396 
Figure 4: Difference in the calculated electrostatic potential between “wild type” p53 and 19 different mutants 397 
of residue R249. The change in the profile is shown for every residue located within 15Å of the mutated 398 
residue. These residues are ordered according to the distance to the R249 starting from the nearest one. The 399 
profiles indicate that the changes have an impact beyond the position of the mutation altering residues found 400 
in distinct functional domains of the p53 protein, this is shown in the highest peaks. In the bottom of the 401 
figure is shown a schema of the domain and residues present in p53 [50]. 402 
Figure 5: Calculated electrostatic potential for the residue Arg249 and the 19 variants generated with the 403 
scanning mode of the MutantElec system using the input PDB_ID:1TUP [40]. It is possible to observe the 404 
major change in the electrostatic potential for the residues with negative charge like Asp y Glu. 405 
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Figure 6: Analysis of the more significant change for the residue 249 for p53 protein. A: show amino acids 406 
that were most affected by the respective in silico mutations with respect to the wild type protein, this are the 407 
residues Tyr163, His168, Met246, Glu171, Ser166, Glu285 in decreasing order of magnitude. B: Spatial 408 
distribution of these residues, it is possible to observe some of these residues are located at less than 5Å to the 409 
mutated Arg249 except the residue Glu285 (>10Å). 410 
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Table 1: Description of the files that are sent to the user after the calculations have finished. 
 
File Name Description 
protein.in 
 
Configuration file for APBS calculations 
protein.pdb 
 
Coordinate file uploaded by the user 
proteinWT-Mutant.pdb Coordinate file for the mutant protein generated by Mutator. 
proteinWT-Mutant.pqr File containing information about atomic charge and radius information, 
necessary for the calculations with APBS software. 
_aminopot.txt Electrostatic potential for each amino acid expressed in mVolts. 
_atompot.txt Electrostatic potential for each atom expressed in mVolts. 
_map.dx Electrostatic maps to display in Pymol or VMD 
_ distances.txt File with the distances from the mutated residue and the remaining amino 
acids of the protein 
_detailedValues.csv Electrostatic potential differences between the input and mutant protein 
 _testResults.txt File with the result of the Wilcoxon Signed-Rank Test 
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Figure 1 workflow of the MutantElect web application. The three layers are color-coded and the components 
of each layer are represented accordingly. External software packages used in the pipeline are represented 
by the parallelogram while in-house developments (scripts and subroutines) are shown as rectangles. INPUT 
layer (N° 1). Routine used to upload the input PDB file and to define the mutations to be performed. 
ANALYSIS layer (N° 2). Module employed in the generation of the in silico mutations and the calculation of 
the electrostatic potential. OUTPUT layer (N° 3). Subroutines in charge of performing the statistical analyses 
and comparisons and in generating the output.  
Figure 1  
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Figure 2: Consulting web interface of MutantElec. A: Analysis options, namely “site-specific” or “specific 
region” of the target protein and entry form for input data upload. B: Calculation parameters and default 
values (temperature = 298.15 K (mesophilic conditions); dielectric constant of the water = 78.54; distance 
cutoff (radio of selection for the analysis) from the residue mutated = 15Å. C: Site-directed mutations 
selection scroll-down menu. The option “All (Scanning)” allows the calculation to be repeated 19 times for 
every other of the 19 possible residues.  
Figure 2  
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Figure 3: MutantElec analyzes. A: Combinatorial chart displaying the electrostatic potential of the input and 
mutant proteins, and the difference in potential between both. B: Scheme of the environment surrounding 
the mutated residue (Glu100Ile) for the protein FurPA (PDB_ID:1MZB) [12]. In red are residues around the 
mutated residue (in blue) within the selected sphere of 15Å ratio used for the analysis. This distance can be 
modified by the user in the parameter setting web page with the option “Distance cutoff”.  
Figure 3  
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Figure 4: Difference in the calculated electrostatic potential between “wild type” p53 and 19 different 
mutants of residue R249. The change in the profile is shown for every residue located within 15Å of the 
mutated residue. These residues are ordered according to the distance to the R249 starting from the nearest 
one. The profiles indicate that the changes have an impact beyond the position of the mutation altering 
residues found in distinct functional domains of the p53 protein, this is shown in the highest peaks. In the 
bottom of the figure is shown a schema of the domain and residues present in p53 [51].  
Figure 4  
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Figure 5: Calculated electrostatic potential for the residue Arg249 and the 19 variants generated with the 
scanning mode of the MutantElec system using the input PDB_ID:1TUP [39]. It is possible to observe the 
major change in the electrostatic potential for the residues with negative charge like Asp y Glu.  
Figure 5  
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Figure 6: Analysis of the more significant change for the residue 249 for p53 protein. A: show amino acids 
that were most affected by the respective in silico mutations with respect to the wild type protein, this are 
the residues Tyr163, His168, Met246, Glu171, Ser166, Glu285 in decreasing order of magnitude. B: Spatial 
distribution of these residues, it is possible to observe some of these residues are located at less than 5Å to 
the mutated Arg249 except the residue Glu285 (>10Å).  
Figure 6  
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Supplementary material 
 
Figure 1S: “Site-specific mutagenesis” workflow. The user can choose between two options for generating the 
mutation: (i) Select one specific amino acid  or (ii) select scanning mode. The latter repeats the calculation 19 
time for every other of the 19 amino acid. The comparison between the electrostatic potential of the  input 
protein and each mutant is calculated and the link to check the results are sent to the user by email.  
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Figure 2S: “Mutation of a specific region” workflow. The user has to choose the zone in which to carry out 
the mutagenesis. The system permits the analysis of a region of 10 residues changing each of the specific 
amino acid selected for mutation. The comparison between the electrostatic potential of the input protein and 
each mutant is calculated and the results are sent to the user. 
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Figure 3S: Examples of graphs generated and provided on the MutantElec website. A: Electrostatic potential 
of the input protein. B: Electrostatic potential of the mutant protein. C: Electrostatic potential of the input and 
mutant protein. D: Difference in electrostatic potential.  
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Figure 4S: Representation of the electrostatic potential maps for residue 249 for the p53 protein 
(PDB_ID:1TUP) [35].  Negative charges are shown in red and positive charges in blue. A: Representation of 
the electrostatic potential map for the region neighboring residue Arg249 for the wildtype protein. B: 
Representation of the electrostatic potential map for the region neighboring residue 249 for the mutant protein 
Arg249Glu. Is possible observe the region near to the residue 249 is negatively charged due to the change of 
Arg for Glu.  
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Table 1S. Comparison of web applications for mutation analysis.  Comparison of existing web applications that study the effect of mutations in parameters 
such as binding affinity or binding free energy. The applications were evaluated in 5 aspects with regards to usability: “File submission” (whether it requires the 
user uploads the PDB file or if he can just input a code), “Job submission” (how friendly and intuitive is the interface to submit a job), “Mutation interface” (does 
it require the user to manually input residue number, names, or are they shown, so the user only has to click them?), “Results” (are they easy to understand?), 
“Response time” (how long does a job take to finish). Also, there is a column with other observations that didn’t fit the above criteria, and a score from 0 to 10, 
where 0 correspond to a bad usability/bad response time and results, and 10  an intuitive and user-friendly interface with good usability and results easy to 
understand. In all cases, the platform where tested with the 1CSE pdb, and 3 mutations (if they were allowed). 
Name Application File submission Job submission Mutation interface Results Other observations 
Response 
time 
Score 
MutaBind 
 
http://www.ncbi
.nlm.nih.gov/pr
ojects/mutabind 
It evaluates the effects of 
variations and disease 
mutations on protein-protein 
interactions. It predicts if a 
mutation disrupts an 
interaction and calculates the 
change in binding affinity. 
The structure of a protein-
protein complex is required 
for this method. 
It provides the 
option to enter the 
PDB identifier or 
upload a custom 
PDB file 
There's a drag-and-drop 
interface, which allows for 
an intuitive use in selecting 
partners of interaction. A 
representation of the PDB 
file is also shown, 
highlighting the different 
chains. 
Doesn't require 
knowledge of the 
exact information in 
the PDB, because it is 
shown dynamically on 
the web page. It also 
provides th  option of 
doing several 
mutations. 
A table is shown, in which, 
by each mutation, the change 
of binding affinity is shown, 
whether is deleterious or not, 
and its confidence. The 
mutated PDB files can be 
downloaded. 
The web page design 
is highly modern. It's 
usability is user-
friendly, and intuitive. 
29 
estimated 
8/10 
BeatMusic 
 
http://babylone.
ulb.ac.be/beatm
usic/ 
Prediction of binding affinity 
changes upon mutations. 
It provides the 
option to enter the 
PDB identifier or 
upload a custom 
PDB file 
A list with all chains of the 
PDB file is shown, and the 
user must select the first 
and the second partner of 
the protein-protein 
interaction. 
Doesn't require 
knowledge of the 
exact information in 
the PDB, because it is 
shown dynamically on 
the web page. 
However, only up to 
10 mutations can be 
performed. 
A table is shown, in which, 
by each mutation, the change 
of binding affinity is shown. 
If it increases or decreases 
the binding affinity, the result 
is highlighted. 
The web page design 
is highly influenced by 
music. The menu is 
shown in musical 
terms, such as "Play", 
"Listen" or "Learn". 
This may distract an 
user, and it also makes 
the platform hard to 
take seriously. 
~1 minute 9/10 
SAAMBE 
 
http://compbio.c
lemson.edu/saa
mbe_webserver/ 
Predicting the effect of single 
amino acid substitution on 
the binding free energy of 
protein complexes. 
It doesn't allow the 
basic option of 
submitting a PDB 
file with just its 
identifier. The PDB 
file must be 
uploaded. 
There's no validation in the 
selection of the partners of 
the protein complexes. 
They should be known a 
priori. This could present a 
difficulty in biologists that 
don't know much about a 
The exact position, 
chain, and aminoacid 
to be mutated must be 
known and manually 
entered, which may 
lead to errors, as is 
isn't validated. This is 
The original and the mutated 
PDB files can be 
downloaded. The calculation 
results include the change in 
several energy parameteres. 
This is delivered in a plain 
text file. 
Only one mutation can 
be done. 
~15 
minutes 
4/10 
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PDB file. Since the 
partners can't be selected 
on the web page, if one 
inputs the wrong code, the 
job will end with no 
results. Even more, the 
error file just says "Wild 
type", which doesn't help 
at all. 
also cumbersome for 
people with less 
computational 
knowledge, as it may 
impede the correct 
usage of the platform. 
 
Also, "Valine" can't be 
selected as a residue 
(nor original or as a 
mutation). 
SAAFEC 
 
http://compbio.c
lemson.edu/SA
AFEC/ 
Calculating folding free 
energy changes in proteins 
caused by missense 
mutations. 
It doesn't allow the 
basic option of 
submitting a PDB 
file with just its 
identifier. The PDB 
file must be 
uploaded. 
There's only one interface 
to enter the mutations, and 
then the job can be 
submitted. 
The exact position, 
chain, and aminoacid 
to be mutated must be 
known and manually 
entered, which may 
lead to errors, as is 
isn't validated. This is 
also cumbersome for 
people with less 
computational 
knowledge, as it may 
impede the correct 
usage of the platform. 
A table with the change of 
several energy parameters is 
shown. Also, the original and 
the mutated PDB files can be 
downloaded. The calculation 
can also be downloaded as a 
plain text file. 
Only one mutation can 
be done. 
~15 
minutes 
5/10 
Delphi 
 
http://compbio.c
lemson.edu/sap
p/delphi_webser
ver/ 
Online Poisson-Boltzmann 
solver for calculating 
electrostatic energies and 
potential in biological 
macromolecules. 
It doesn't allow the 
basic option of 
submitting a PDB 
file with just its 
identifier. The PDB 
file must be 
uploaded. 
The interface guides the 
user through several pages, 
in which several 
parameters of the 
electrostatic potential 
calculations can be 
specified. In this regard, 
Delphi is highly 
customizable. However, 
this may deter users that 
just want to see a potential 
map, as they'll see the web 
page as something 
complex. 
Mutations can't be 
performed. The 
platform is only 
directed at the 
calculation of 
electrostatic potentials. 
The results are shown in a 
web page, with a Jmol applet, 
in which the user may watch 
the electrostatic potential 
map. The results are also 
available for download. 
The results page uses 
Jmol. This may 
present difficulties for 
the users, since that 
requires the Java 
Runtime Environment. 
There're several 
security issues with 
Java, and in some 
computers is not 
allowed to use it, 
making it impossible 
for the user to see the 
results in a quick an 
efficient way. 
~20 
minutes 
4/10 
PoPMuSiC 
 
https://soft.dezy
me.com/query/c
reate/pop 
Predicts the change in folding 
free energy upon mutation. 
It provides the 
option to enter the 
PDB identifier or 
upload a custom 
PDB file 
There's only one interface 
to enter the mutations, and 
then the job can be 
submitted. 
The exact position, 
chain, and aminoacid 
to be mutated must be 
known and manually 
entered, which may 
lead to errors. Even 
though it is validated, 
it doesn't offer any 
The results are delivered in a 
plain text file, and also in a 
very detailed way, in a 
colored and user-friendly 
page. 
It requires registration. 
Also, the user's guide 
is outdated. 
<1 minute 7/10 
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help to solve the issue. 
This is also 
cumbersome for 
people with less 
computational 
knowledge, as it may 
impede the correct 
usage of the platform. 
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Table 2S:  Relationship between amino acid position in  p53 and the number of mutants available in p53 
(information  obtained from the IARC TP53 database, [45]). In highlight are shown the amino acids that 
undergo significant changes of electrostatic potential in the mutation MutantElecR249X as predicted by 
MutantElec. 
Amino acid 
position 
Number 
of 
mutants 
 
Amino acid 
position 
Number 
of 
mutants 
 
Amino acid 
position 
Number 
of 
mutants 
246 9  156 4  42 1 
281 9  159 4  46 1 
113 8  175 4  49 1 
242 8  178 4  57 1 
245 8  194 4  62 1 
248 8  195 4  75 1 
249 8  208 4  89 1 
279 8  213 4  92 1 
286 8  214 4  108 1 
132 7  236 4  116 1 
134 7  237 4  118 1 
152 7  243 4  119 1 
238 7  247 4  121 1 
239 7  250 4  123 1 
241 7  254 4  124 1 
244 7  262 4  144 1 
270 7  266 4  146 1 
273 7  267 4  154 1 
275 7  285 4  161 1 
120 6  305 4  164 1 
127 6  98 3  171 1 
130 6  111 3  174 1 
135 6  133 3  181 1 
151 6  145 3  196 1 
157 6  155 3  202 1 
158 6  168 3  209 1 
176 6  172 3  211 1 
193 6  177 3  212 1 
205 6  179 3  217 1 
215 6  276 3  223 1 
219 6  282 3  231 1 
258 6  297 3  233 1 
259 6  306 3  235 1 
272 6  330 3  252 1 
278 6  332 3  256 1 
280 6  341 3  263 1 
109 5  27 2  264 1 
110 5  34 2  271 1 
126 5  97 2  284 1 
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143 5  107 2  295 1 
162 5  117 2  296 1 
163 5  131 2  300 1 
173 5  138 2  308 1 
216 5  139 2  316 1 
220 5  140 2  342 1 
232 5  147 2  348 1 
234 5  197 2  350 1 
251 5  199 2  351 1 
255 5  200 2  361 1 
257 5  218 2  364 1 
265 5  240 2  375 1 
274 5  253 2    
277 5  260 2    
337 5  283 2    
105 4  293 2    
122 4  304 2    
125 4  344 2    
136 4  347 2    
141 4  36 1    
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The electrostatic potential plays a key role in many biological processes like determining the 
affinity of a ligand to a given protein target, and they are responsible for the catalytic activity 
of many enzymes. Understanding the effect that amino acid mutations will have on the 
electrostatic potential of a protein, will allow a thorough understanding of which residues are 
the most important in a protein this is essential for the drug design.  
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